FITZROYPARTNERS

Alan's career in the biosciences comprises basic research, investment management/capital markets and strategic consultancy. Starting his career as a chemist at Merck & Co., Inc. after his academic work he joined McKinsey & Company, the international management consultancy. He subsequently became Director at Commerzbank Asset Management ($140bn AUM) in London and Frankfurt in charge of global equity bio-investments as well as overall industrial investment research. He co-founded, took public in the US and was first CEO and CFO of Chiral Quest, Inc., a life sciences company in the area of chiral pharmaceuticals. He is Royal Society Entrepreneur in Residence and Visiting Lecturer at Oxford University and serves as CEO of Oxford Drug Design. Alan earned his BA (Hons) from Cornell University, PhD in organic chemistry from Columbia University, and Postdoctoral Fellowship from the University of Oxford. Having authored several scientific publications and received academic awards and fellowships, he holds a Guest Professorship at Tianjin University in.